Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormalities. However, the molecular basis for this genome instability remains unknown. Since both impaired and hyperactive double strand break (DSB) repair pathways can result in DNA rearrangements, we investigated the functionality of DSB repair in MM cells. Repair kinetics of ionizing-radiation (IR)-induced DSBs was similar in MM and normal control lymphoblastoid cell lines, as revealed by the comet assay. However, four out of seven MM cell lines analyzed exhibited a subset of persistent DSBs, marked by γ-H2AX and Rad51 foci that elicited a prolonged G2/M DNA damage checkpoint activation and hypersensitivity to IR, especially in the presence of chec...
Multiple myeloma (MM) is a malignant hemopathy characterized by clonal proliferation of pla...
PARP inhibitors can induce synthetic lethality in tumors characterized by homologous recombination d...
Background Multiple Myeloma (MM) is a hematological malignancy with genomic heterogeneity and poor ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormaliti...
Human myeloma cell lines (HMCLs) and a subset of myeloma patients with poor prognosis exhibit high l...
Ongoing genomic instability represents a hallmark of multiple myeloma (MM) cells, which manifests la...
Multiple myeloma (MM) is characterized by multiple chromosomal aberrations. To assess the contributi...
Multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal plasma cell...
Background: Multiple myeloma (MM) is a plasma cells malignancy charac- terized by a complex and hete...
marrowplasma cells that accounts for 10% of all hematological malignancies.The broad clinical spectr...
DNA Interstrand Crosslinks (ICLs) are complex DNA lesions generated by bi-functional alkylating agen...
DNA double-strand breaks (DSBs) are a significant threat to the viability of a normal cell, since th...
To gain insight into multiple myeloma (MM) tumorigenesis, we analyzed the mutational signatures in 8...
Multiple myeloma (MM) is a malignant hemopathy characterized by clonal proliferation of pla...
PARP inhibitors can induce synthetic lethality in tumors characterized by homologous recombination d...
Background Multiple Myeloma (MM) is a hematological malignancy with genomic heterogeneity and poor ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormaliti...
Human myeloma cell lines (HMCLs) and a subset of myeloma patients with poor prognosis exhibit high l...
Ongoing genomic instability represents a hallmark of multiple myeloma (MM) cells, which manifests la...
Multiple myeloma (MM) is characterized by multiple chromosomal aberrations. To assess the contributi...
Multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal plasma cell...
Background: Multiple myeloma (MM) is a plasma cells malignancy charac- terized by a complex and hete...
marrowplasma cells that accounts for 10% of all hematological malignancies.The broad clinical spectr...
DNA Interstrand Crosslinks (ICLs) are complex DNA lesions generated by bi-functional alkylating agen...
DNA double-strand breaks (DSBs) are a significant threat to the viability of a normal cell, since th...
To gain insight into multiple myeloma (MM) tumorigenesis, we analyzed the mutational signatures in 8...
Multiple myeloma (MM) is a malignant hemopathy characterized by clonal proliferation of pla...
PARP inhibitors can induce synthetic lethality in tumors characterized by homologous recombination d...
Background Multiple Myeloma (MM) is a hematological malignancy with genomic heterogeneity and poor ...